Circulating leptin levels were reduced in both ALS stages in TDP-43A315T mice compared to age-matched controls, being significantly lower at disease termination in the affected mice (F(3, 12)=3.875, p = 0.03; Figure 2A). The gene discussed is LEP; the disease is amyotrophic lateral sclerosis.